Expertise
About
Ryan Suk, PhD, is a health economist and decision scientist by training. She is currently an assistant professor on the tenure track at Nell Hodgson Woodruff School of Nursing, with a secondary appointment in the Department of Health Policy and Management at Rollins School of Public Health at Emory University. Suk also serves as a faculty consultant for Health Economics and Outcomes Research at the Winship Center for Cancer Health Equity Research of the Winship Cancer Institute.
Her primary research centers on the prevention and control of HPV-associated cancers and the optimization of patient-centered integrative and palliative oncology in cancer survivorship. Suk focuses on using real-world data, decision modeling, and community-partnered methods to evaluate healthcare efficiency, inform individual health decision-making, and guide implementation strategies, with particular emphasis on under-recognized populations.
Suk received a bachelor's degree in business administration from Korea University, a master's degree in economics from the University of Utah, and after completing her PhD coursework at the University of Florida, a doctoral degree in health economics from the University of Texas Health Science Center (UTHealth) Houston School of Public Health. Before joining Emory, she served as an assistant professor at the University of Florida College of Pharmacy and the UTHealth Houston School of Public Health.
Education
- Bachelor of Business Administration (BBA), Korea University, Seoul
- Master of Science (MS) in Economics, University of Utah, Salt Lake City
- Doctor of Philosophy (PhD) in Health Economics, University of Texas, Houston
- Postdoctoral Fellowship in Decision Science, University of Texas, Houston
Professional Organizations
- Member/Trustee, Society for Medical Decision Making (SMDM)
- Member, International Papillomavirus Society (IPVS)
- Member, American Cancer Society National HPV Vaccination Roundtable
- Member, HPV Vaccination Roundtable of the Southeast
- Member, Society for Integrative Oncology
